Extracorporeal Adsorption Therapy: A Method to Improve Targeted Radiation Delivered by Radiometal-Labeled Monoclonal Antibodies
Eneida R. Nemecek(Oregon Health & Science University), Oliver W. Press(Fred Hutch Cancer Center), D. Scott Wilbur(University of Washington), John M. Pagel(University of Washington), Yukang Lin(Fred Hutch Cancer Center), Darrell R. Fisher(Richland Community College), Rune Nilsson, Lawrence D. Durack(University of Washington), Bengt Sandberg(Active Biotech (Sweden)), Ajay K. Gopal(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Joseph G. Rajendran(Fred Hutch Cancer Center), Damian J. Green(Sylvester Comprehensive Cancer Center)
Cited by 5
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.9k
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2020|1.9k
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2014|1.7k
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
|New England Journal of Medicine|2021|1.6k